BlueCrest Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,380	Closed	-$269K	–	890
2019 Q1	$269K	Buy	21,380 +7,092	+50%	+$89.2K	0.01%	762
2018 Q4	$96K	Sell	14,288 -5,213	-27%	-$35K	﹤0.01%	758
2018 Q3	$201K	Sell	19,501 -47,778	-71%	-$492K	0.01%	1254
2018 Q2	$452K	Buy	+67,279	New	+$452K	0.01%	863